光活性纳米疫苗的使用.
Qihang Ding1,2, Siyu Chen1, Siwei Hua2
1Brain Center, Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Ministry of Education Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, 430071, China. mjgu@whu.edu.cn.
Chemical Society reviews
|September 22, 2025
概括
光激活纳米疫苗使用对光敏感的纳米材料,用于增强癌症免疫疗法和预防传染病. 将这些与光动力学或光热疗法相结合,可以提高免疫反应和治疗效率.
科学领域:
- 纳米技术和免疫学
- 生物医学工程 生物医学工程
- 药物输送系统 药物输送系统
背景情况:
- 光激活纳米疫苗利用对光敏感的纳米材料来精确控制免疫反应.
- 最近在辅助剂,纳米载体和光敏感剂 (PSs) 等成分方面的进展提高了纳米疫苗的疗效.
- 对刺激有反应的载体提供了受控的疫苗释放,最大限度地减少了非目标效应.
研究的目的:
- 系统地审查光激活纳米疫苗的原则,设计策略和应用.
- 探索光动力疗法 (PDT) 和光热疗法 (PTT) 与纳米疫苗的整合.
- 讨论这些先进疫苗临床转换的新兴趋势和挑战.
主要方法:
- 关于光激活纳米疫苗技术近期突破的文献综述.
- 对纳米载体系统,光敏剂和辅助剂集成的分析.
- 检查联合治疗策略,包括PDT和PTT,以提高免疫性.
主要成果:
- 光活性纳米疫苗显示增强了抗原呈现和免疫激活.
- 与PDT/PTT的整合诱导免疫细胞死亡 (ICD) 并调节瘤微环境 (ITME).
- 这些系统引发了强大的抗瘤免疫力,并促进了对病原体的长期免疫记忆.
结论:
- 光激活纳米疫苗代表了癌症免疫疗法和传染病控制的有希望的平台.
- 多模式治疗策略和个性化方法是未来的关键方向.
- 克服临床翻译挑战对于实现这些下一代疫苗的全部潜力至关重要.
更多相关视频
11:07Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
13.7K
08:27Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
5.0K
相关概念视频
Cancer Vaccines
974
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
974
Vaccinations
51.3K
Overview
51.3K
